| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fmr Llc | Other*, 10%+ Owner | Feb 3, 2025 | |||
| ARCH Venture Partners XII, LLC | 10%+ Owner | Feb 3, 2025 | |||
| Joshua Pinto | Director | Jan 30, 2025 | |||
| Christopher Whitten Bernard | President and Chief Executive Officer; Exhibit 24.1 - Power of Attorney, Director, 10%+ Owner | Jan 30, 2025 | |||
| Clive Meanwell | Executive Chairman, Director, 10%+ Owner | Jan 30, 2025 | |||
| Validae Health, L.P. | 10%+ Owner | Jan 30, 2025 | |||
| Steven Marso | Chief Medical Officer | Jan 30, 2025 | |||
| Kristina Burow | Director, 10%+ Owner | Feb 3, 2025 | |||
| Brian Hubbard | Chief Scientific Officer | Jan 30, 2025 | |||
| Christopher Visioli | Chief Financial Officer | Jan 30, 2025 | |||
| Paul L. Berns | Director | Feb 3, 2025 | |||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | Jan 30, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|